Elle DigestLifestyle, beauty and consumer releases

Health & Medical · Week of Nov 9, 2026

PAVmed, Photocure update Medicare status: the week in health releases

PAVmed, Photocure, Health Net, ComplexCare Solutions and CeraVe also issued news; Medicare coverage and payment featured in diagnostics updates.

· Elle Digest newsroom

Medicare reimbursement ran through two diagnostics updates this week. PAVmed says its subsidiary Lucid Diagnostics began receiving Medicare payments for the EsoGuard test in October after submitting claims to Novitas. Photocure says its AssureMDx bladder cancer test was left out of a Novitas Local Coverage Determination dated November 6, 2026, and that it still expects coverage in 2028, in line with its original assumption.

On the financial side, Health In Tech reported a lower third-quarter revenue figure, a net loss and a reduced full-year outlook alongside a CEO change. Aflac raised its quarterly dividend, and ComplexCare Solutions refinanced its credit facilities. Other releases covered a Health Net housing investment, a CeraVe film marketing tie-in and a set of dental pulp research papers from the American Association of Endodontists.

  1. Health In Tech, Inc.

    Health In Tech Reports Third Quarter 2026 Financial Results

    Health In Tech reported Q3 2026 revenue of $6.6 million and a net loss of $7.1 million, including a $5.3 million provision for credit losses, and cut its full-year 2026 revenue outlook to approximately $30 million, citing delays from a transition to a new carrier. Sanjay Shrestha became CEO effective October 20, 2026, with founder Tim Johnson moving to Executive Chairman, and the company reported 984 distribution partners, up 15.9% year over year.

  2. PAVmed Inc.

    PAVmed Provides Business Update and Reports Preliminary Third Quarter 2026 Financial Results

    PAVmed says Lucid Diagnostics began receiving Medicare payments for EsoGuard in October at the established Clinical Laboratory Fee Schedule rate, after performing 2,871 tests and recognizing $1.2 million in revenue in 3Q26. The company also says Veris Health reached design freeze on its implantable monitor ahead of a planned early 2027 FDA 510(k) submission, and reported cash and cash equivalents of $8.9 million, including $5.3 million of restricted cash.

  3. ComplexCare Solutions

    ComplexCare Solutions Closes Refinancing with Regions Bank and Pinnacle Bank, Lowering Cost of Capital and Enabling Long-term Growth

    ComplexCare Solutions, a Vesey Street Capital Partners portfolio company, closed a refinancing with Regions Bank and Pinnacle Bank consisting of a revolving credit facility and a Term Loan A with an accordion feature. The company says the deal lowers its interest rate and extends its debt maturity to 2031.

  4. Aflac Incorporated

    Aflac Incorporated Announces 4.9% Increase in the First Quarter 2027 Dividend

    Aflac Incorporated declared a first quarter 2027 dividend of $0.64 per share, a 4.9% increase over the previously declared fourth quarter 2026 dividend, payable March 1, 2027, to shareholders of record on February 17, 2027. Chairman and CEO Daniel P. Amos cited 44 consecutive years of dividend increases.

  5. Health Net, LLC

    For 75 San Joaquin County Families, Affordable Housing May be Within Reach thanks to Health Net

    Health Net, a Centene Corporation company, announced a $3 million investment in the San Joaquin Regional Housing Fund to support at least 75 affordable homes for Stockton families earning between 30% and 50% of the area median income. Health Net says it has invested a combined $11 million in affordable housing and related initiatives in Sacramento and San Joaquin counties.

  6. CeraVe

    CeraVe Becomes "The Official Moisturizer of Arrakis" in First-Ever Film Partnership with DUNE: PART THREE

    CeraVe announced its first official film partnership, with Warner Bros. Pictures and Legendary Pictures' Dune: Part Three, branding itself "The Official Moisturizer of Arrakis" in a campaign centered on CeraVe Moisturizing Cream. The campaign runs through the film's theatrical release, which begins December 18, 2026 in North America and December 16 internationally.

  7. Photocure

    Photocure Provides Update on AssureMDx and Anticipated Medicare Coverage Timeline

    Photocure says AssureMDx was not included in the Novitas Local Coverage Determination dated November 6, 2026, which identifies additional clinical evidence needed for future reconsideration, and that it expects Medicare coverage in 2028 as originally assumed. The company says a CMS pricing determination is expected before year-end 2026, taking effect January 1, 2027, and it still expects initial AssureMDx revenue in 2027.

  8. American Association of Endodontists (AAE)

    Can Damaged Teeth Heal Themselves? New Research Explores the Future of Saving Natural Teeth

    The American Association of Endodontists says its Journal of Endodontics November 2026 issue includes 15 papers on dental pulp preservation and regeneration from the 2025 Pulp Biology and Regeneration Group Symposium in Madrid. The studies cover dental pulp stem cells, inflammation, diagnostic markers and pain, and the release says a review of apical periodontitis does not establish that dental infections cause cardiovascular disease.

This roundup is written with AI assistance from the press releases listed above, using only what they state. The releases are the companies' own announcements, not Elle Digest reporting.